Publications by authors named "Paul Bunn"

100Publications

Guidance on the Clinical Management of Electronic Cigarette or Vaping-Associated Lung Injury.

J Thorac Oncol 2020 Aug 29. Epub 2020 Aug 29.

Department of Medicine Penn State College of Medicine, Penn State Cancer Institute, Hershey, Pennsylvania. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2020.08.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455516PMC
August 2020

How gradual retirement has allowed me to spend more time with family and being physically active.

Authors:
Paul A Bunn

Clin Adv Hematol Oncol 2020 Jan;18(1):17-18

University of Colorado School of Medicine, Aurora, Colorado.

View Article

Download full-text PDF

Source
January 2020

A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers.

Cancer Prev Res (Phila) 2019 10 15;12(10):721-730. Epub 2019 Jul 15.

Division of Pulmonary Sciences and Critical Care Medicine, Eastern Colorado VA Healthcare System, Rocky Mountain Regional VA Medical Center, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-19-0006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774885PMC
October 2019

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium.

J Thorac Oncol 2019 09 20;14(9):1666-1671. Epub 2019 Jun 20.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.06.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708730PMC
September 2019

Adi Gazdar, MD: Physician, Pathologist, Scholar, Collaborator, Friend.

Authors:
Paul Bunn

J Thorac Oncol 2019 04;14(4):742-743

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.02.021DOI Listing
April 2019

New Developments in Neoadjuvant Therapy for Lung Cancer.

Oncology (Williston Park) 2019 Mar;33(3):101-6, 109

View Article

Download full-text PDF

Source
March 2019

Advancements in Small-cell Lung Cancer: The Changing Landscape Following IMpower-133.

Clin Lung Cancer 2019 05 2;20(3):148-160.e2. Epub 2019 Jan 2.

University of Colorado Cancer Center, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.12.019DOI Listing
May 2019

Broad-Based Molecular Testing for Lung Cancer: Precisely the Time for Precision.

JAMA 2018 08;320(5):445-446

University of Colorado Cancer Center, University of Colorado, Denver, Aurora.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2018.10096DOI Listing
August 2018

Systemic Therapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancers.

J Clin Oncol 2018 09 20;36(25):2571-2574. Epub 2018 Jul 20.

Paul A. Bunn Jr and Anastasios Dimou, University of Colorado Denver and University of Colorado Cancer Center, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.2457DOI Listing
September 2018

The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC.

Drug Des Devel Ther 2018 24;12:981-986. Epub 2018 Apr 24.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
https://www.dovepress.com/the-combination-of-anti-kir-monocl
Publisher Site
http://dx.doi.org/10.2147/DDDT.S163304DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923225PMC
September 2018

Eribulin inhibits the growth of small cell lung cancer cell lines alone and with radiotherapy.

Lung Cancer 2018 04 4;118:148-154. Epub 2018 Feb 4.

University of Colorado, Cancer Center and Department of Medicine, United States; University of Colorado, Division of Medical Oncology, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.02.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916851PMC
April 2018

Small-cell lung cancer: what we know, what we need to know and the path forward.

Nat Rev Cancer 2017 Nov 10;17(12):765. Epub 2017 Nov 10.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc.2017.106DOI Listing
November 2017

Advances in lung cancer.

Oncotarget 2017 Oct 13;8(45):78247-78248. Epub 2017 Sep 13.

Paul A. Bunn: Department of Medicine, Division of Medical Oncology, University of Colorado Cancer Center, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.20854DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667952PMC
October 2017

Small-cell lung cancer: what we know, what we need to know and the path forward.

Nat Rev Cancer 2017 12 27;17(12):725-737. Epub 2017 Oct 27.

Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75230-8593, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc.2017.87DOI Listing
December 2017

Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer.

Anticancer Drugs 2017 11;28(10):1086-1096

aMerrimack Pharmaceuticals, Cambridge, Massachusetts bDivision of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000545DOI Listing
November 2017

Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung.

J Thorac Oncol 2018 01 24;13(1):134-138. Epub 2017 Aug 24.

Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.08.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810959PMC
January 2018

Robert Comis, MD, The Passing of a "Lung Man".

Authors:
Paul A Bunn

J Thorac Oncol 2017 08;12(8):1323-1324

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.06.014DOI Listing
August 2017

HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.

Cancer 2017 Nov 25;123(21):4099-4105. Epub 2017 Jul 25.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30869DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650517PMC
November 2017

PreMeta: a tool to facilitate meta-analysis of rare-variant associations.

BMC Genomics 2017 02 14;18(1):160. Epub 2017 Feb 14.

Department of Biostatistics, University of North Carolina, Chapel Hill, 37203, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12864-017-3573-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310051PMC
February 2017

Karnofsky Award 2016: A Lung Cancer Journey, 1973 to 2016.

Authors:
Paul A Bunn

J Clin Oncol 2017 01 7;35(2):243-252. Epub 2016 Nov 7.

From University of Colorado Cancer Center, Aurora, CO.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.70.4064
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.70.4064DOI Listing
January 2017

KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.

Oncotarget 2016 Dec;7(50):82104-82111

Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.13486DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347678PMC
December 2016

Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench.

J Thorac Oncol 2017 01 15;12(1):27-35. Epub 2016 Sep 15.

Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327855PMC
January 2017

New and emerging targeted treatments in advanced non-small-cell lung cancer.

Lancet 2016 Sep 1;388(10048):1012-24. Epub 2016 Sep 1.

Department of Medicine, Division of Medical Oncology and Department of Pathology, University of Colorado Cancer Center, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S014067361631473
Publisher Site
http://dx.doi.org/10.1016/S0140-6736(16)31473-8DOI Listing
September 2016

Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo.

Mol Cancer Ther 2016 10 5;15(10):2314-2322. Epub 2016 Aug 5.

Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050114PMC
http://dx.doi.org/10.1158/1535-7163.MCT-16-0298DOI Listing
October 2016

Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status.

Lung Cancer 2016 06 26;96:27-32. Epub 2016 Mar 26.

Department of Medicine, Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.03.007DOI Listing
June 2016

Simultaneous inference on treatment effects in survival studies with factorial designs.

Biometrics 2016 12 17;72(4):1078-1085. Epub 2016 Mar 17.

Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina 27599, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/biom.12507DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026867PMC
December 2016

Neoadjuvant combination chemotherapy for unresectable stage III non-small cell lung cancer.

Cancer 2016 Mar 23;122(5):674-5. Epub 2015 Dec 23.

Department of Surgery, University of Colorado Cancer Center, Denver, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29797DOI Listing
March 2016

Adjuvant TKIs in NSCLC: what can we learn from RADIANT?

Nat Rev Clin Oncol 2015 Dec 10;12(12):689-90. Epub 2015 Nov 10.

Division of Medical Oncology, University of Colorado, 12801 East 17th Avenue, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2015.202DOI Listing
December 2015

Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.

Oncologist 2015 Oct 1;20(10):1175-81. Epub 2015 Sep 1.

Mount Sinai Health Systems, New York, New York, USA; Pfizer Oncology, New York, New York, USA; Cone Health Cancer Center, Greensboro, North Carolina, USA; Carolinas Pathology Group, Carolinas HealthCare System, Charlotte, North Carolina, USA; Chao Family Comprehensive Cancer Center, University of California at Irvine School of Medicine, Orange, California, USA; US Oncology Research, Ocala, Florida, USA; Carolinas HealthCare System, Charlotte, North Carolina, USA; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; University of Colorado Cancer Center, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591939PMC
October 2015

Improving the Care of Patients With Stage IB Non-Small-Cell Lung Cancer: Role of Prognostic Signatures and Use of Cell Cycle Progression Biomarkers.

Clin Lung Cancer 2015 Jul 6;16(4):245-51. Epub 2015 Mar 6.

Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2015.02.008DOI Listing
July 2015

Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.

Oncologist 2015 Mar 26;20(3):316-22. Epub 2015 Feb 26.

Thoracic Cancer Research and Detection Center, Sheba Medical Center, Ramat Gan, Israel; Tel Aviv University, Tel Aviv, Israel; University of Colorado Cancer Center, Division of Medical Oncology, University of Colorado, Aurora, Colorado, USA; Oncotest, Teva Pharmaceutical Industries Ltd., Petah Tikva, Israel; Thoracic Cancer Unit, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel; Foundation Medicine, Cambridge, Massachusetts, USA; The Institute of Oncology, Wolfson Medical Center, Holon, Israel

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0389DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350802PMC
March 2015

Personalized one-two punches for lung cancer.

Cell Res 2015 Mar 30;25(3):269-70. Epub 2014 Dec 30.

1] Program in Molecular Biology, University of Colorado Cancer Center, Aurora, CO 80045, USA [2] Department of Biochemistry and Molecular Genetics, University of Colorado Cancer Center, Aurora, CO 80045, USA [3] Department of Medicine, School of Medicine, University of Colorado Cancer Center, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/cr.2014.168DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349242PMC
March 2015

Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.

J Thorac Oncol 2015 Jan;10(1 Suppl 1):S1-63

*Department of Medical Oncology, Washington University School of Medicine, Saint Louis, Missouri; Departments of †Medical Oncology and ‡Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; §Department of Medical Oncology, University of Colorado School of Medicine and University of Colorado Cancer Center, Aurora, Colorado; ‖UCLA Santa Monica Hematology Oncology, Santa Monica, California; ¶Division of Hematology-Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; #Department of Medical Oncology, Yale School of Medicine and Cancer Center, New Haven, Connecticut; **Massachusetts General Hospital Cancer Center, Boston, Massachusetts; ††Department of Oncology, The University of Chicago Medicine, Chicago, Illinois; ‡‡Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee; §§Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, Georgia; ‖‖Memorial Sloan-Kettering Cancer Center, New York, New York; ¶¶Division of Hematology-Oncology, Medical University of South Carolina, Charleston, South Carolina; ##Sarah Cannon Research Institute, Nashville, Tennessee; ***The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; †††Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas; and ‡‡‡Division of Medical Oncology, University of Colorado Denver School of Medicine, Denver, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346098PMC
January 2015

Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.

J Clin Oncol 2014 Dec 27;32(34):3824-30. Epub 2014 Oct 27.

Puneeth Iyengar, Zabi Wardak, Irma Smith, Chul Ahn, David E. Gerber, Jonathan Dowell, Randall Hughes, Ramzi Abdulrahman, Hak Choy, Robert Timmerman, University of Texas Southwestern Medical Center, Dallas, TX; Brian D. Kavanagh, D. Ross Camidge, Laurie E. Gaspar, Robert C. Doebele, and Paul A. Bunn, University of Colorado School of Medicine, Aurora, CO.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.56.7412
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.7412DOI Listing
December 2014

Reply to A. Braillon.

J Clin Oncol 2014 Nov 15;32(31):3575. Epub 2014 Sep 15.

University of Colorado Cancer Center, Aurora, CO

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.2545DOI Listing
November 2014

"Companion diagnostics": has their time come and gone?

Clin Cancer Res 2014 Sep 24;20(17):4422-4. Epub 2014 Jul 24.

Department of Medicine, Smillow Cancer Center, Yale School of Medicine, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-14-0932DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155019PMC
September 2014

FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.

Clin Cancer Res 2014 Jun 25;20(12):3299-309. Epub 2014 Apr 25.

Authors' Affiliations: Departments of Medicine, Pathology, Craniofacial Biology, and Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, Colorado; ARIAD Pharmaceuticals, Inc., Cambridge, Massachusetts; Medical University of Gdańsk, Poland; and Department of Prostate Cancer Research, Institute of Pathology, University Hospital of Bonn, Bonn, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-3060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062100PMC
June 2014

Is there clinical value to prognostic signatures in early-stage NSCLC?

Clin Cancer Res 2014 Apr 28;20(7):1727-9. Epub 2014 Feb 28.

Authors' Affiliations: Division of Medical Oncology, Departments of Medicine and Pathology, University of Colorado Cancer Center, University of Colorado Denver, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-3387DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998101PMC
April 2014

Recent clinical advances in lung cancer management.

J Clin Oncol 2014 Apr 24;32(10):973-82. Epub 2014 Feb 24.

University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.1228DOI Listing
April 2014

Progress in research on screening and genetics in lung cancer.

Lancet Respir Med 2014 Jan 23;2(1):19-21. Epub 2013 Dec 23.

Division of Medical Oncology, School of Medicine, University of Colorado Denver, Research Center 1 South Tower, 12801 E 17th Avenue, 8th Floor, Campus Box 8117, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(13)70264-9DOI Listing
January 2014

Exploring the relationship between technology use, hearing help-seeking, and hearing aid outcomes in older adults.

Int J Audiol 2014 Feb 8;53 Suppl 1:S38-42. Epub 2014 Jan 8.

* HEARing CRC , Melbourne , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/14992027.2013.847287DOI Listing
February 2014

Effective crizotinib schedule for brain metastases in ALK rearrangement metastatic non-small-cell lung cancer.

J Thorac Oncol 2013 Dec;8(12):e112-3

*The Thoracic Cancer Research and Detection Center, †The Radiation Institute, Sheba Medical Center, Tel Aviv University, Tel-Aviv, Israel; and ‡University of Colorado Cancer Center, Division of Medical Oncology, University of Colorado Denver, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000038DOI Listing
December 2013

The evolution of tumor classification: a role for genomics?

Cancer Cell 2013 Dec;24(6):693-4

Division of Medical Oncology, Department of Medicine, School of Medicine, University of Colorado, Denver, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2013.11.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928679PMC
December 2013

Lung cancer in 2013: state of the art therapy for metastatic disease.

Am Soc Clin Oncol Educ Book 2013 :339-46

From the Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; University of Colorado Denver, Aurora, CO; Medical Oncology Department, Instituto de Biomedicina de Sevilla and Hospital Universitario Virgen del Rocío, Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2013.33.339DOI Listing
April 2016

Volatile fingerprints of cancer specific genetic mutations.

Nanomedicine 2013 Aug 18;9(6):758-66. Epub 2013 Feb 18.

Thoracic Cancer Research and Detection Center, Sheba Medical Center, Tel-Hashomer, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nano.2013.01.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186653PMC
August 2013

Worldwide overview of the current status of lung cancer diagnosis and treatment.

Authors:
Paul A Bunn

Arch Pathol Lab Med 2012 Dec;136(12):1478-81

Division of Medical Oncology, University of Colorado, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2012-0295-SADOI Listing
December 2012

Non-invasive breath analysis of pulmonary nodules.

J Thorac Oncol 2012 Oct;7(10):1528-33

Thoracic Cancer Research and Detection Center, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182637d5fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444531PMC
October 2012

Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition.

Cancer Res 2012 Aug 27;72(16):4154-64. Epub 2012 Jun 27.

Department of Biochemistry and Molecular Genetics, Program in Molecular Biology, University of Colorado School of Medicine, Aurora, Colorado 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-2848DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673784PMC
August 2012

A new generation of EGFR tyrosine-kinase inhibitors in NSCLC.

Lancet Oncol 2012 May 26;13(5):442-3. Epub 2012 Mar 26.

University of Colorado, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(12)70124-9DOI Listing
May 2012

Classification of lung cancer histology by gold nanoparticle sensors.

Nanomedicine 2012 Jul 25;8(5):580-9. Epub 2011 Oct 25.

The Department of Chemical Engineering and Russell Berrie Nanotechnology Institute, Technion-Israel Institute of Technology, Haifa, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nano.2011.10.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745892PMC
July 2012

Oral iloprost improves endobronchial dysplasia in former smokers.

Cancer Prev Res (Phila) 2011 Jun;4(6):793-802

Division of Pulmonary Sciences and Critical Care Medicine, Eastern Colorado VA Healthcare System, University of Colorado Denver, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-11-0057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251330PMC
June 2011

ZEB1-responsive genes in non-small cell lung cancer.

Cancer Lett 2011 Jan 25;300(1):66-78. Epub 2010 Oct 25.

Division of Hematology-Oncology, Department of Medicine and the Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2010.09.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337721PMC
January 2011

The tissue is the issue: personalized medicine for non-small cell lung cancer.

Clin Cancer Res 2010 Oct 5;16(20):4909-11. Epub 2010 Oct 5.

University of Colorado Cancer Center, Aurora, Colorado 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2005DOI Listing
October 2010

Lessons learned from the systematic evaluation of cutaneous T-cell lymphomas at the national cancer institute and the roadmap for future studies.

Clin Lymphoma Myeloma Leuk 2010 Sep;10 Suppl 2:S74-9

Department of Medicine, University of Colorado Cancer Center, University of Colorado Denver, Aurora.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLML.2010.s.012DOI Listing
September 2010

Optimal therapy for elderly patients with early stage non-small cell lung cancer.

Authors:
Paul A Bunn

Am J Respir Crit Care Med 2010 Feb;181(3):201-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.200910-1558EDDOI Listing
February 2010